557 — China Tian Yuan Healthcare Share Price
Last trade - 00:00- HK$351.10m
- HK$342.13m
- HK$26.85m
- 25
- 13
- 45
- 13
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.81 | ||
| Price to Tang. Book | 2.26 | ||
| Price to Free Cashflow | 29.45 | ||
| Price to Sales | 17.19 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -15.2% | ||
| Return on Equity | -15.15% | ||
| Operating Margin | -155.41% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 56.34 | 94.59 | 54.22 | 45.23 | 26.84 | n/a | n/a | -17.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Tian Yuan Healthcare Group Ltd is an investment holding company mainly engaged in the medical business. The Company operates its business through four segments. The Healthcare segment is engaged in the provision of testing, diagnostic and management services for self-operated hospitals, sales of craniofacial implant products, licensing of trademarks and plastic surgery services. The Money Lending and Related Business segment is engaged in loan financing, related services and commission or trade processing fees for loan matching. The Investment Holding segment is engaged in the investment of listed equity securities. The Hospitality segment is engaged in providing procurement services related to the hospitality industry.
Directors
- Huabing Wang CHM (51)
- Wei Dong CEO (28)
- Wai Hung Chow SEC
- Mei He NED (33)
- Yuan Zhou NED (29)
- Jingbin Guo NID (63)
- Baihe Hu NID (56)
- Kwok Kuen Yuen NID (45)
- Last Annual
- December 31st, 2024
- Last Interim
- June 30th, 2025
- Incorporated
- January 1st, 1970
- Public Since
- December 29th, 1989
- No. of Employees
- 31
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 398,980,000
- Address
- 11/F., 80 Gloucester Road, Wanchai
- Web
- https://www.tianyuanhealthcare.com
- Phone
- +852 null25681008
- Auditors
- Crowe (HK) CPA Limited
Upcoming Events for 557
Similar to 557
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Bayzed Health
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:41 UTC, shares in China Tian Yuan Healthcare are trading at HK$0.88. This share price information is delayed by 15 minutes.
Shares in China Tian Yuan Healthcare last closed at HK$0.88 and the price had moved by +44.26% over the past 365 days. In terms of relative price strength the China Tian Yuan Healthcare share price has outperformed the FTSE Developed Asia Pacific Index by +24.88% over the past year.
There is no consensus recommendation for this security.
Find out moreChina Tian Yuan Healthcare does not currently pay a dividend.
China Tian Yuan Healthcare does not currently pay a dividend.
China Tian Yuan Healthcare does not currently pay a dividend.
To buy shares in China Tian Yuan Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.88, shares in China Tian Yuan Healthcare had a market capitalisation of HK$351.10m.
Here are the trading details for China Tian Yuan Healthcare:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 557
Based on an overall assessment of its quality, value and momentum China Tian Yuan Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Tian Yuan Healthcare. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -13.36%.
As of the last closing price of HK$0.88, shares in China Tian Yuan Healthcare were trading +23.51% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The China Tian Yuan Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.88.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
China Tian Yuan Healthcare's management team is headed by:
- Huabing Wang - CHM
- Wei Dong - CEO
- Wai Hung Chow - SEC
- Mei He - NED
- Yuan Zhou - NED
- Jingbin Guo - NID
- Baihe Hu - NID
- Kwok Kuen Yuen - NID